QHSLab, Inc.

QHSLab, Inc.

USAQ - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$3.89M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
QHSLab, Inc.QHSLab, Inc.9-29%--
$-0.35

Current Fair Value

237% downside

Overvalued by 237% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$3.89 Million
Enterprise Value$3.70 Million
Earnings per Share$0.04
Beta0.7
Outstanding Shares15,032,788

Return

Return on Equity29.06%ROE
Return on Assets24.96%
Return on Invested Capital33.17%

Valuation & Multiples

P/E Ratio8.97P/E Ratio
PEG-3.46PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue1.25
Enterprise Value to EBIT7.41
Enterprise Value to Net Income8
Total Debt to Enterprise0
Debt to Equity0Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 17, 2026
EPS Estimate
-$0.01
Consensus analyst estimate
Revenue Estimate
$300,000
Consensus analyst estimate

Next Earnings Call

Expected Date
April 1, 2027
EPS Estimate
-$0.02
Consensus analyst estimate
Revenue Estimate
$400,000
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About QHSLab, Inc.

12 employees
CEO: Troy James Grogan

QHSLab, Inc. is a company operating in the medical technology and Software-as-a-Service (SaaS) sectors. Its core focus is on advancing value-based healthcare, medical informatics, and personalized medicine driven by algorithms. The firm ...

Questions & Answers